Literature DB >> 23381985

Fungal meningitis in an immunocompetent patient.

Ricardo Louro1, Rui Ferreira, Catarina Pinheiro, Helena Parada, Domitília Faria, Edmeia Monteiro.   

Abstract

Cryptococcal meningitis is a rare entity among immunocompetent hosts but, when it occurs, it is associated with significant morbidity and mortality. Clinical presentation as well as the course of the disease is usually subtle and indolent with headache and altered mental status. The authors present the case of a 59-year-old man, who sought medical help with a 2-week history of headaches accompanied by nausea and visual and hearing disturbances. On admission the patient was afebrile, presented visual and hearing deficits and had a normal magnetic resonance image of the brain. A lumbar puncture was performed and microscopic examination of the cerebrospinal fluid revealed yeasts that were identified as Cryptococcus spp. and later, by means of molecular biology techniques, as Cryptococcus neoformans, var. grubii. The patient was treated with liposomal amphotericin B plus fluconazole for 28 weeks. At follow-up after 1 year the patient was asymptomatic and received fluconazole 400 mg/day as prophylactic therapy. The outcome of Cryptococcus infections in immunocompetent hosts is reported to be poor as a result of a delayed diagnosis and suboptimal initial antifungal therapy. The influence of the normal immune response is unclear.

Entities:  

Mesh:

Year:  2013        PMID: 23381985     DOI: 10.1007/s40261-012-0021-5

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  5 in total

1.  The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy.

Authors:  Ismail Zafer Ecevit; Cornelius J Clancy; Ilona M Schmalfuss; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

2.  Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B.

Authors:  Sharon C A Chen
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

Review 3.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Cryptococcal meningitis: clinical, diagnostic and therapeutic overviews.

Authors:  P Satishchandra; T Mathew; G Gadre; S Nagarathna; A Chandramukhi; A Mahadevan; S K Shankar
Journal:  Neurol India       Date:  2007 Jul-Sep       Impact factor: 2.117

5.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

  5 in total
  2 in total

1.  Cryptococcal meningitis initially presenting with eye symptoms in an immunocompetent patient: A case report.

Authors:  Jun Li; Peipei Wang; Ling Ye; Yanfang Wang; Xiuzhen Zhang; Songping Yu
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

2.  Audiologic and Otologic Complications of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Patients.

Authors:  Kelly A King; Ghedak Ansari; Anil A Panackal; Chris Zalewski; Seher Anjum; John E Bennett; Andrea Beri; Hung Jeff Kim; Dima Hammoud; Carmen C Brewer; Peter R Williamson
Journal:  Otol Neurotol       Date:  2019-07       Impact factor: 2.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.